P. Delmotte

发表

Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trial

D. Annane, L. Puybasset, S. Demeret, 2022, Critical Care.

Biochemical findings in multiple sclerosis

P. Delmotte, R. Gonsette, C. Ketelaer, 1976, Journal of Neurology.

Biochemical findings in multiple sclerosis

P. Delmotte, L. Demonty, 1976, Journal of Neurology.

Separation of Proteins and Other Compounds by Capillary Isotachophoresis

P. Delmotte, 1981 .

Electrophoresis of cerebrospinal fluid proteins

H. Carton, P. Delmotte, 1981, Clinical Neurology and Neurosurgery.

In Vivo Activation of Serum Complement by Contrast Media: A Clinical Study

P. Delmotte, R. Gonsette, 1980, Investigative radiology.

Failure of basic protein therapy for multiple sclerosis

P. Delmotte, L. Demonty, R. Gonsette, 1977, Journal of Neurology.

Clinical parameters and intrathecal IgG synthesis as prognostic features in multiple sclerosis. Part I

H. Carton, P. Theys, P. Delmotte, 2004, Journal of Neurology.

LYMPHOCYTE-T SUB-POPULATIONS IN MULTIPLE-SCLEROSIS LESIONS

S. Poppema, O. Hommes, P. Delmotte, 1982 .

Biochemical findings in multiple sclerosis

P. Delmotte, C. Ketelaer, 2004, Journal of Neurology.

Intensive immunosuppression with cyclophosphamide in multiple sclerosis

P. Delmotte, L. Demonty, R. Gonsette, 1977, Journal of Neurology.

The Cerebrospinal Fluid Immunoglobulins in Multiple Sclerosis

P. Delmotte, 1986 .

Biochemical findings in multiple sclerosis

H. Carton, P. Delmotte, F. Gosseye-Lissoir, 1977, Journal of Neurology.

Cell‐mediated immunity in multiple sclerosis as determined by sensitivity of different lymphocyte populations to various brain tissue antigens

O. Hommes, K. Lamers, W. Nillesen, 1982, Annals of neurology.

Measles Antibodies, Anti-Proteinase and Plasminogen Distribution in Serum and Plasma from Patients Affected with Multiple Sclerosis and Patients Affected with Non-Neurological Diseases

F. Bollengier, A. Mahler, P. Delmotte, 1984 .

Intensive Immunosuppression with Cyclophosphamide in Remittent Forms of Multiple Sclerosis. A Follow-Up of 134 Patients for 2–10 Years

P. Delmotte, L. Demonty, R. Gonsette, 1980 .

Gel isoelectric focusing of cerebrospinal fluid proteins: a potential diagnostic tool

P. Delmotte, 1971, Zeitschrift fur klinische Chemie und klinische Biochemie.

The constitution of monorden, an antibiotic with tranquilising action

N. Bhacca, A. Scott, F. McCapra, 1964 .

A New Antifungal Substance of Fungal Origin

P. Delmotte, J. Delmotte-Plaquée, 1953, Nature.

Modulation of immunity in multiple sclerosis: a double-blind levamisole-placebo controlled study in 85 patients

J. Symoens, J. Decree, P. Delmotte, 2004, Journal of Neurology.

Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study

P. Demondion, P. Leprince, B. Guidet, 2020, The Lancet Respiratory Medicine.

Immunosuppression with cyclophosphamide in multiple sclerosis

P. Delmotte, L. Demonty, R. Gonsette, 1984 .

Immunological and Clinical Aspects of Multiple Sclerosis

P. Delmotte, R. Gonsette, 1984, Springer Netherlands.

[Comparative results of agar electrophoresis and electrofocalization examination of gamma globulins of the cerebrospinal fluid].

P. Delmotte, 1972, Acta neurologica Belgica.

Biochemical findings in multiple sclerosis

A. Lowenthal, F. Bollengier, P. Delmotte, 2004, Journal of Neurology.

[Paper and agar gel electrophoresis of the cerebrospinal fluid proteins in multiple sclerosis and other neurological diseases. Results in 266 cases].

P. Delmotte, J. Sténuit, 1972, Acta neurologica Belgica.

Evaluation of the Blood/CSF Permeability Coefficients and of the Intrathecal Synthesis of IgG by Capillary Isotachophoresis

P. Delmotte, 1980 .

Measurement of Blood/CSF Permeability Coefficients and of Intrathecal Synthesis of IgG by Capillary Isotachophoresis

P. Delmotte, 1979 .